Advances in gene sequencing led to game-changing biological discoveries and created significant shareholder value in the life sciences industry. We're seeing similar trends emerging in Proteomics - a discipline that studies proteins, one of the key building blocks of life. It is a logical next step in life sciences discovery, and like genomics before it, will yield transformative innovations and investment opportunities. Amati managers Mikhail Zverev and Graeme Bencke will discuss some of the implications on the upcoming Amati Insight call.